Evidence map›Paper›PMID 37546282›Full record

ArticleObesity science & practice2023

The impact of age and obesity on outcomes among patients hospitalized with COVID-19 in Denmark: A nationwide cohort study.

Anton Lund Andersen, Sigrid Bjerge Gribsholt, Lars Pedersen, Reimar Wernich Thomsen, Thomas Lars Benfield, Ole Søgaard, Stig Lønberg Nielsen, Lars Haukali Omland, Birgitte Lindegaard, Bjørn Richelsen and 2 more

Abstract read
In one paragraph

Article in Obesity science & practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anton Lund AndersenSteno Diabetes Centre Aarhus Aarhus University Hospital Aarhus N Denmark.ORCID https://orcid.org/0000-0002-2339-2911
Sigrid Bjerge GribsholtSteno Diabetes Centre Aarhus Aarhus University Hospital Aarhus N Denmark.
Lars PedersenDepartment of Clinical Epidemiology Aarhus University Hospital Aarhus N Denmark.
Reimar Wernich ThomsenDepartment of Clinical Epidemiology Aarhus University Hospital Aarhus N Denmark.
Thomas Lars BenfieldDepartment of Infectious Diseases Copenhagen University Hospital, Amager and Hvidovre Hvidovre Denmark.
Ole SøgaardDepartment Infectious Disease Aarhus University Hospital Aarhus Denmark.
Stig Lønberg NielsenDepartment of Infectious Diseases Odense University Hospital Odense Denmark.
Lars Haukali OmlandDepartment of Infectious Diseases Copenhagen University Hospital, Rigshospitalet Copenhagen Denmark.
Birgitte LindegaardDepartment of Clinical Medicine Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark.
Bjørn RichelsenSteno Diabetes Centre Aarhus Aarhus University Hospital Aarhus N Denmark.
Jacob BodilsenDepartment of Infectious Diseases Aalborg University Hospital Aalborg Denmark.
Jens Meldgaard BruunSteno Diabetes Centre Aarhus Aarhus University Hospital Aarhus N Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Obesity may alter the severity of infection with Coronavirus disease 2019 (COVID-19). Age may impact the association between body weight and severity of COVID-19 in patients with obesity. The aim of the study was to examine the association between obesity and severity of infection in a Danish cohort hospitalized with COVID-19 in the initial wave of the pandemic. Patients and methods: Based on data from the nationwide, clinical database: COVID-DK, risks of intensive care unit (ICU) admission, invasive mechanical ventilation (IMV), and mortality were compared among patients with and without obesity. Interaction with age was examined and we used Inverse Probability of Treatment Weighting regression for confounder adjustment. Results: Among 524 patients, 142 (27%) were admitted to the ICU, 112 (21%) required IMV, and 109 (21%) died. Compared to COVID-19 patients without obesity, patients with obesity displayed a non-significant increased risk of ICU admission (Relative Risk [RR] 1.19, 95% Confidence Interval [CI] 0.88; 1.60), IMV (RR 1.23, CI 0.86; 1.75) and mortality (RR 1.21, CI 0.84; 1.75). COVID-19 patients with obesity, <60 years had highly increased risk of ICU admission (RR 1.92, CI 1.14; 3.24) and IMV (RR 1.95, CI 1.09; 3.49). Conclusions: In hospitalized COVID-19 patients, obesity conferred an approximately 20% increased risk for ICU admission, IMV, and death, although these relationships did not reach statistical significance. COVID-19 patients with obesity and <60 years had an almost doubled risk of ICU admission and IMV.

Indexed as

body mass index (BMI)infectionsmortalityobesity

Identifiers

PMID37546282
PMCPMC10399535

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.